PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Recruiting now · Phase 3

Conditions studied: Lymphoma

In brief

The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.

Key facts

Study ID

NCT03647072

Run by

Sherief Abd-Elsalam

People needed

60

Starts

2018-08-01

Expected to finish

2027-12-01

Last updated by the study team

2018-08-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DLBCL Lymphoma subtype --No comorbid disease

You may not qualify if…

• Pregnancy
• Peptic ulcer
• Severe cardiac disease
• Osteoporosis

Where it is running

• Sherief Abd-Elsalam — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.